Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Citi
Chubb
Federal Trade Commission
AstraZeneca

Generated: August 18, 2019

DrugPatentWatch Database Preview

Patent: 5,929,099

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,929,099
Title: Pharmaceutical composition for inhibiting the growth of cancers
Abstract:A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals and can be used to treat viral infections that comprises a fungicide in combination with chemotherapeutic agents is disclosed. The particular fungicide used is a benzimidazole derivative. Potentiators can also be included in the composition.
Inventor(s): Camden; James Berger (West Chester, OH)
Assignee: Procter & Gamble Co. (Cincinnati, OH)
Application Number:08/680,470
Patent Claims:see list of patent claims

Details for Patent 5,929,099

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Procter & Gamble Co. (Cincinnati, OH) 2036-04-30 RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 5,929,099

Country Patent Number Publication Date
South Africa 9602879 Mar 17, 1997
South Africa 9604373 Sep 02, 1996
World Intellectual Property Organization (WIPO) 9632107 Oct 17, 1996
World Intellectual Property Organization (WIPO) 9640122 Dec 19, 1996
World Intellectual Property Organization (WIPO) 9959585 Nov 25, 1999
United States of America 2001027205 Oct 04, 2001
United States of America 2002198247 Dec 26, 2002
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Daiichi Sankyo
Citi
Fuji
Queensland Health
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.